卒中后急性心肌梗死患者临床特点和近期预后的分析

被引:6
作者
李静
华琦
谭静
李东宝
刘志
李博宇
范振兴
邵强
机构
[1] 首都医科大学宣武医院心脏科
基金
北京市自然科学基金;
关键词
心肌梗死; 卒中; 预后; 危险因素;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)]; R542.22 [];
学科分类号
100204 [神经病学];
摘要
目的评价既往具有卒中病史的患者出现急性心肌梗死的临床特点、住院期间不良事件和病死率。方法纳入1994年1月—2006年12月初发心电图ST段抬高的心肌梗死患者1233例,其中男901例,女332例,按照是否有卒中病史分为卒中组(158例)和对照组(1075例),比较两组患者的临床特点、危险因素、住院并发症和病死率。结果①与对照组相比,卒中组患者年龄大,不典型症状多,发病至就诊时间长,接受再灌注治疗的比例较低,差异均具有统计学意义,P<0.05;②主要危险因素比较后,卒中组的高血压(69.7%)、糖尿病(30.3%)患者比例高于对照组(43.4%和14.5%),吸烟比例(41.0%)低于对照组(50.5%),差异有统计学意义,P<0.05;③卒中组与对照组比较住院期间急性脑血管事件(3.0%对0.8%)、心房颤动(6.5%对2.5%)、室性心动过速(3.2%对1.0%)、心力衰竭(42.9%对22.9%)和病死率(17.6%对9.5%),差异有统计学意义,P<0.05;④对死亡原因进行分析,卒中组因呼吸衰竭死亡的比例高于对照组(14.2%对2.9%),因心脏破裂死亡的比例低于对照组(14.3%对34.3%),差异均有统计学意义,P<0.05。结论卒中后急性心肌梗死患者的年龄大,危险因素较多,接受再灌注治疗的比例较低,住院期间更易出现并发症,临床工作中应高度重视。
引用
收藏
页码:505 / 509
页数:5
相关论文
共 7 条
[1]
各类脑血管疾病诊断要点[J] 中华神经科杂志 1996, 06
[2]
Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study[J] Inbal Boger-Megiddo;Susan R Heckbert;Noel S Weiss;Barbara McKnight;Curt D Furberg;Kerri L Wiggins;Joseph A C Delaney;David S Siscovick;Eric B Larson;Rozenn N Lemaitre;Nicholas L Smith;Kenneth M Rice;Nicole L Glazer;Bruce M Psaty BMJ: British Medical Journal 2010,
[3]
Ischaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial infarction[J] Ergelen;Gorgulu;Uyarel;Norgaz;Ayhan;Akkaya;Ergelen;Cicek;Ugur;Soylu;Tezel;Yekeler Acta Cardiologica 2009,
[4]
Symptoms of a first acute myocardial infarction in women and men[J] Gender Medicine 2009,
[5]
Acute ST-segment elevation myocardial infarction and prior stroke: An analysis from the Magnesium in Coronaries (MAGIC) trial[J] Howard A. Cooper;Michael J. Domanski;Yves Rosenberg;James Norman;Judith H. Scott;Susan F. Assmann;Sonja M. McKinlay;Judith S. Hochman;Elliott M. Antman American Heart Journal 2004,
[6]
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study[J] Gad Cotter;Christopher P. Cannon;Carolyn H. McCabe;Yoav Michowitz;Edo Kaluski;Andrew Charlesworth;Olga Milo;Jane Bentley;Alex Blatt;Rikardo Krakover;Reuven Zimlichman;Leonardo Reisin;Alon Marmor
[7]
Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction[J] Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman;Jose Luis Lopez Sendon;Lars Rydén;Maarten Simoons;Michal Tendera Journal of the American College of Cardiology 2000,